MiNK Therapeutics, Inc. (INKT)
NASDAQ: INKT · Real-Time Price · USD
10.95
+0.22 (2.05%)
At close: Apr 24, 2026, 4:00 PM EDT
10.94
-0.01 (-0.09%)
After-hours: Apr 24, 2026, 7:03 PM EDT
MiNK Therapeutics Market Cap
MiNK Therapeutics has a market cap or net worth of $54.38 million as of April 24, 2026. Its market cap has increased by 75.53% in one year.
Market Cap
54.38M
Enterprise Value
45.05M
1-Year Change
75.53%
Ranking
Category
Stock Price
$10.95
Market Cap Chart
Since the IPO on October 15, 2021, MiNK Therapeutics's market cap has decreased from $386.36M to $54.38M, a decrease of -85.93%. That is a compound annual growth rate of -35.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2026 | 53.28M | 1.80% |
| Dec 31, 2025 | 52.34M | 89.51% |
| Dec 31, 2024 | 27.62M | -25.23% |
| Dec 29, 2023 | 36.94M | -58.11% |
| Dec 30, 2022 | 88.18M | -40.99% |
| Dec 31, 2021 | 149.43M | -61.32% |
| Oct 15, 2021 | 386.36M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Instil Bio | 55.48M |
| Entera Bio | 54.55M |
| Cue Biopharma | 54.12M |
| Metagenomi Therapeutics | 53.80M |
| Kezar Life Sciences | 53.71M |
| PDS Biotechnology | 51.80M |
| Rein Therapeutics | 51.59M |
| Radiopharm Theranostics | 50.77M |